trending Market Intelligence /marketintelligence/en/news-insights/trending/nihpnhou5rvaqhkx9pwc3q2 content esgSubNav
In This List

Biohaven Pharmaceutical director resigns

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Biohaven Pharmaceutical director resigns

Biohaven Pharmaceutical Holding Co. Ltd. said Albert Cha notified the company of his intent to step down as the company's director, effective Sept. 7.

The company said Cha's resignation was not a result of any disagreement with the company or the board.

New Haven, Conn.-based Biohaven Pharmaceutical is a clinical-stage biopharmaceutical company that develops product candidates to treat neurological diseases, including rare disorders.